Search
for
Sort by
Research 121–150 of 601
- Lifestyle Drugs
- Phytochemistry and Pharmacological Studies of Glycyrrhiza glabra: A Medicinal Plant Review
- Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3
- Nanotechnology Based Herbal Hair Cosmetics a Review
- Contents
- Comprehensive Program Planning for the Integration of 21st Century Learning Center After-School Programs with Regular Day Programs and Community Partners.
- Increasing Importance traditional remedies in the Hair Care Industry in India
- Molecular Genetics of Alopecias
- Was the epidemic skin disease of 1891 due to acute arsenic poisoning?
- Androgenetic alopecia: pathogenesis and potential for therapy
- Oxidative stress in ageing of hair
- Keratin disorders: from gene to therapy
- Differentiation of Mouse Induced Pluripotent Stem Cells into a Multipotent Keratinocyte Lineage
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Aging of hair
- No evidence for the immunocompetence handicap hypothesis in male humans
- Mechanical forces in skin disorders
- An Overview of Alopecias
- Alopecia areata update
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- The Basic Science of Hair Biology
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- The histopathology of alopecia areata in vertical and horizontal sections
- Hypothalamic DNA methylation in rats with dihydrotestosterone‐induced polycystic ovary syndrome: effects of low‐frequency electro‐acupuncture
- Trias of keratosis pilaris, ulerythema ophryogenes and 18p monosomy: Zouboulis syndrome
- Analysis of genetic polymorphisms of steroid 5α-reductase type 1 and 2 genes in Korean men with androgenetic alopecia
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- Integrated Model of Care for Polycystic Ovary Syndrome
- THE FREQUENCY OF VISCERAL AND PHENOTYPIC MARKERS IN PATIENTS WITH THE COMBINATION OF UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE AND GASTROESOPHAGEAL REFLUX DISEASE